Pricing Log in Create free account
Saturday 17 October 2026 Export BACK’s income statement to Excel — free account

IMAC Holdings, Inc.

BACK Healthcare Medical Care Facilities

IMAC Holdings, Inc.’s revenue for fiscal 2024 (year ended December 2024) was $72,100.00, down 99.6% from fiscal 2022. In the quarter to September 2025, revenue grew 34.2%, EPS grew 16.7% and free cash flow fell 30.9%, each against the same quarter a year earlier.

0.00 0.00 NaN
Market cap
$150.0K
P/E
0.0×
Fwd P/E
−0.6×
Dividend yield
—
F-score
n/a
Altman Z
−73.66
Beneish M
n/a
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Dec 25 Mar 26 Jun 26 Sep 26
Buy — — — — — — — — — — — —
Sell — — — — — — — — — — — —
Insider Ownership 57.46%

Capital & Financial Ratios $m

Market Cap 0.15
Revenue 0.08
Net Income (12.45)
Free Cash Flow (4.90)
Net Debt (0.05)
Current Ratio 0.02 (below 1: weak)
Debt/Equity 0.00 (at or below 0.5: strong)
P/E ratio 0.00
Fwd P/E (0.63) (negative: loss-making)
P/S ratio 0.00
P/B ratio 0.00
Past 5Y EPS Growth —
This Y EPS Growth 70.13% (at or above 15%: strong)
Next Y EPS Growth (37.55%) (below 0%: weak)
Next Y revenue growth (52.43%) (below 0%: weak)
Next 5Y EPS Growth —

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years
EV/Sales is 0.8×, against a ten-year median of 0.9×; over the ten years it ranged from 0.2× in 2022 to 7.5× in 2025.
EV/Sales against its own 10 years 44.62%
10-year low 10-year high

Dividends

Payout Ratio —
Annual Dividend Rate —
Annual Dividend Yield —
total individual payouts
2023 Powerpack
2022 Powerpack
2021 Powerpack
2020 Powerpack
2019 Powerpack
special payouts not included in total or ratios

Assets vs Liabilities $m

2022 2023 2024 Q'25
Cash 1 0 1 0
Receivables 3 — 0 —
Inventory — — — —
Other 0 — — —
11 1 1 0
2022 2023 2024 Q'25
Payables 1 0 3 5
ST’ Debt — — — —
Other 0 — — —
6 2 7 13

Compound Annual Growth %

10y 5y 3y
Sales — (59.60%) (82.22%)
Cash Flow — 0.00% 0.00%
Earnings — 0.00% 0.00%
Book Value — 0.00% 0.00%

Revenue $m

Mar Jun Sep Dec Year
’26 0 — 0 — —
’24 2 1 2 0 0
’22 4 5 4 3 16
’21 3 3 3 4 14
’20 3 3 3 3 13
’19 3 4 4 4 15
’18 0 1 3 3 7
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 (1) (1) (1) — —
’24 0 (1) (1) (1) (3)
’23 (1) 0 (1) 0 (3)
’22 (3) (3) (2) (2) (10)
’21 (2) (3) (1) (2) (8)
’20 (1) (2) (1) (2) (6)
’19 (1) (1) (1) (1) (4)
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 (1) (1) (1) — —
’24 0 (1) (1) (1) (3)
’23 (1) 1 (1) 0 (2)
’22 (3) (3) (2) (2) (11)
’21 (2) (3) (2) (2) (8)
’20 (1) (2) (1) (2) (6)
’19 (1) (1) (1) (2) (5)
Fiscal quarters ending in the months shown.

EPS $

Mar Jun Sep Dec Year
’26 (1.08) (0.89) (1.15) — —
’24 — (1.72) (1.38) (3.08) (5.76)
’23 (3.30) (1.20) (2.63) (1.25) (8.47)
’22 (3.60) (2.10) (6.91) (6.91) (19.52)
’21 (4.50) (2.40) (3.43) (2.60) (14.04)
’20 (5.41) (6.01) (3.60) 1.20 (13.51)
’19 (8.11) (6.31) (5.71) (4.80) (25.22)
Fiscal quarters ending in the months shown.
value withheld pending a data check

Target Price Range

Analyst price targets

Recommendation Rating

1
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Group Line 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Trend 2025e 2026e 2027e
Price, $
Price, $ Low — — — — 38.40 12.60 31.50 5.40 1.22 0.98

Analyst estimates 2025–2027

Powerpack
High — — — — 216.15 148.50 82.50 44.70 12.15 7.75
People
People Employees — — 95 124 132 139 177 85 4 15
Revenue/emp, $m — 0.00 0.01 0.05 0.11 0.09 0.08 0.19 0.00 0.00
Income, $m
Income, $m Revenue — 0 1 7 15 13 14 16 — 0
Gross margin, % — (1,152.67) 100.00 100.00 100.00 100.00 100.00 100.00 — (323.44)
EBT — 0 (1) (4) (7) (6) (11) (12) (6) (6)
EBT margin, % — (2,649.33) (116.60) (56.48) (45.96) (43.18) (73.28) (73.10) 0.00 (8,734.81)
Net income — 0 (1) (4) (7) (6) (11) (18) (9) (9)
Depreciation — — 0 1 2 2 2 2 0 0
Per share, $
Per share, $ Revenue — 0.00 3.60 44.38 58.58 34.88 19.16 17.17 0.00 0.05
Earnings — (0.05) (4.20) (25.07) (25.22) (13.51) (12.57) (19.52) (8.47) (5.76)
Cash flow — (0.12) (2.00) (11.98) (15.76) (16.29) (10.11) (10.92) (2.51) (2.01)
Capex — 0.00 (2.17) (10.46) (4.08) (1.00) (0.89) (0.28) 0.90 0.00
Free cash flow — (0.12) (4.17) (22.44) (19.84) (17.29) (11.00) (11.20) (1.61) (2.01)
Book value — 0.10 0.79 (26.04) 30.74 21.23 23.91 4.94 (0.68) (3.59)
Shares, m — 7 0 0 0 0 1 1 1 2
Valuation, ×
Valuation, × P/E — 0.00 0.00 0.00 0.00 0.00 0.00 0.00 — 0.00
P/S — 2.49 2.49 2.49 0.77 1.32 1.79 0.34 — 1.22
P/B — 0.00 0.00 0.00 1.46 2.16 1.43 1.17 — 0.00
EV/Sales — 2.58 2.58 2.58 0.89 1.27 1.31 0.30 — 0.98
EV/FCF — (5.09) (5.09) (5.09) (2.64) (2.67) (2.27) (0.46) — (0.64)
Cash, $m
Cash, $m Operating cash flow — (1) 0 (2) (4) (6) (8) (10) (3) (3)
Capex — — 0 (2) (1) 0 (1) 0 1 —
Free cash flow — (1) (1) (3) (5) (6) (8) (11) (2) (3)
Balance, $m
Balance, $m Working capital — 2 0 (13) (3) (1) 4 4 (1) (7)
Total debt — 1 1 1 2 2 0 2 — —
Net debt — (1) 0 1 2 (1) (7) (1) 0 (1)
Shareholders’ equity — 1 0 (4) 8 8 18 5 (1) (6)
Returns, %
Returns, % ROA — (26.44) (3.97) (49.44) (41.26) (27.60) (44.88) (95.60) (156.21) (891.19)
ROIC — 0.00 (99.09) 0.00 (39.37) (56.77) (57.54) (190.28) 0.00 0.00
ROE — (50.29) (12.19) 162.40 (324.45) (70.38) (81.83) (162.03) (489.85) 381.10
Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2024 · latest quarter Sep 2025

Charts ten years each

IMAC Holdings, Inc. vs peers in Medical Care Facilities (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
CANOQ Cano Health, Inc. $6.6M — (loss-making) — −21.05% (below 0%: shrinking) n/m −43.68% (below 0%: shrinking) 100.00% (16.23%) Compare
MODVQ ModivCare Inc. $6.2M — (loss-making) — (loss-making) −3.18% (below 0%: shrinking) n/m −3,767.70% (below 0%: shrinking) 14.06% (1.78%) Compare
BMGL Basel Medical Group Ltd $6.2M — — — — — — — Compare
RHEP Adcare Health Systems Inc $5.2M 0.6× — (loss-making) +143.03% (above 0%: growing) n/m +224.45% (above 0%: growing) 31.50% (0.88%) Compare
NIVF NewGenIvf Group Limited $2.3M — — — — — — — Compare
SYRA Syra Health Corp. $1.1M 84.0× — +23.03% (above 0%: growing) n/m −892.68% (below 0%: shrinking) 44.53% 10.51% Compare
NVOS Novo Integrated Sciences, Inc. $730.0K — (loss-making) — (loss-making) −6.74% (below 0%: shrinking) −43.27% (below 0%: shrinking) −111.85% (below 0%: shrinking) 51.21% (87.60%) Compare
IONM Assure Holdings Corp. $330.0K — (loss-making) — (loss-making) −98.51% (below 0%: shrinking) n/m +95.63% (above 0%: growing) (22,800.00%) (138,800.00%) Compare
BACK IMAC Holdings, Inc. $150.0K — (loss-making) — (loss-making) +34.18% (above 0%: growing) n/m −30.92% (below 0%: shrinking) (484.43%) (12,271.70%)
Median of peers $3.8M — — −4.96% — −77.77% 38.02% (9.00%)

All 55 Medical Care Facilities stocks →

IMAC Holdings, Inc. (BACK) key facts

  • Concern: IMAC Holdings, Inc.’s revenue for fiscal 2024 (year ended December 2024) was $72,100.00, down 99.6% from fiscal 2022.
  • IMAC Holdings, Inc. (BACK) is a Medical Care Facilities company in the Healthcare sector.
  • Return on equity was 381.1% and debt-to-equity 0.00.
  • Its Altman Z-score is −73.66 (distress zone) for fiscal 2024.

Source: company filings (standardised) and stockrow calculations.

IMAC Holdings, Inc. (BACK) Latest News

No news at this impact. Lower the threshold for more.
stockrow.com/BACK · Data as of Sep 30, 2025 · For information only; not investment advice. · © 2026 stockrow.com